Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by PridCor Therapeutics, LLC

News headline image
PridCor Therapeutics Advances Phase 2 SHIELD Study of a Combination Antiviral Regimen for Long COVID Toward Enrollment
From PridCor Therapeutics, LLC
Via GlobeNewswire
News headline image
PridCor Therapeutics Secures Global Antiviral Portfolio, Establishing Leadership in Treatment of Long COVID and Infection-Associated Chronic Illnesses
From PridCor Therapeutics, LLC
Via GlobeNewswire
News headline image
PridCor Therapeutics Advances SHIELD Study Through Dual Regulatory and Scientific Milestones With Peer-Reviewed Publication and FDA IND Exemption for Long COVID Program
From PridCor Therapeutics, LLC
Via GlobeNewswire
News headline image
PridCor Therapeutics Principal Investigator Dr. David Putrino Participates in National Long COVID Roundtable Convened by Secretary Robert F. Kennedy Jr.
From PridCor Therapeutics, LLC
Via GlobeNewswire
News headline image
PridCor Therapeutics Reports Positive Long COVID Case Series with Combination Antiviral Regimen
From PridCor Therapeutics, LLC
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.